Source: Eur Respir J, 53 (5) 1900562; 10.1183/13993003.00562-2019
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Philipp Schuetz, Daiana Stolz. Guiding antibiotic treatment with inflammatory biomarkers in COPD? Another brick in the wall. Eur Respir J, 53 (5) 1900562; 10.1183/13993003.00562-2019

Member's Comments

No comment yet.

Related content which might interest you: Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019 Year: 2019 Double edge sword: antibiotics in the prevention and treatment of COPD exacerbation Source: Annual Congress 2012 - Respiratory infectious diseases Grand Round: an interactive session Year: 2012 Air pollution and inflammatory airway disease: therapeutic options Source: ISSN=1025-448x, ISBN=1-904097-24-3, page=262 Year: 2002 Do we need new therapies for noneosinophilic asthma? Source: Annual Congress 2004 - Noneosinophilic asthma Year: 2004 What is the role of prophylactic antibiotic therapy in chronic bronchitis or COPD? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009 Airway inflammation in asthma: current and future targets and therapies Source: Breathe 2010; 6: 245-252 Year: 2010 Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors Source: International Congress 2014 – Asthma and COPD management Year: 2014 Cleaning agents and chronic lung disease: does the evidence support a link with COPD? Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health? Year: 2018 Bronchiectasis in COPD: increased susceptibility of the airways to aggressive agents? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy Source: Breathe, 15 (4) 296; 10.1183/20734735.0258-2019 Year: 2019 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment Year: 2009 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies Year: 2009 Individual dynamic of inflammatory markers as indicators of COPD treatment effectiveness Source: International Congress 2014 – COPD: points to ponder Year: 2014 Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Is antibiotic treatment during asthma exacerbation necessary ? Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Bacterial resistance induction with prophylactic antibiotics in COPD Source: International Congress 2014 – COPD markers Year: 2014 Air pollution and biomarkers of systemic inflammation and tissue repair in COPD patients Source: Eur Respir J 2014; 44: 603-613 Year: 2014